Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| Viking Therapeutics, Inc. | 191 371 | déclaré | 05 janv. 2026 | tx 104+1 690 502−1 210 563 |
| SANGAMO THERAPEUTICS, INC | 0 | déclaré | 14 févr. 2008 | tx 67+252 875−143 219 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 02 janv. 2026 | GRANT_AWARD | Viking Therapeutics, Inc. | 41 000 | 0.00 USD | |
| 02 janv. 2026 | GRANT_AWARD | Viking Therapeutics, Inc. | 32 049 | 0.00 USD | |
| 05 janv. 2026 | SALE | Viking Therapeutics, Inc. | 31 961 | 32.30 USD | |
| 05 janv. 2026 | SALE | Viking Therapeutics, Inc. | 13 900 | 33.38 USD | |
| 05 janv. 2026 | SALE | Viking Therapeutics, Inc. | 10 300 | 34.24 USD | |
| 05 janv. 2026 | SALE | Viking Therapeutics, Inc. | 1 500 | 32.09 USD | |
| 02 janv. 2026 | GRANT_AWARD | Viking Therapeutics, Inc. | 91 000 | 0.00 USD | deriv |
| 28 oct. 2025 | SALE | Viking Therapeutics, Inc. | 6 185 | 35.00 USD | |
| 27 oct. 2025 | GRANT_AWARD | Viking Therapeutics, Inc. | 11 117 | 0.00 USD | |
| 03 juil. 2025 | SALE | Viking Therapeutics, Inc. | 4 266 | 27.76 USD | |
| 02 juil. 2025 | GRANT_AWARD | Viking Therapeutics, Inc. | 7 667 | 0.00 USD | |
| 03 janv. 2025 | GRANT_AWARD | Viking Therapeutics, Inc. | 44 533 | 0.00 USD | |
| 03 janv. 2025 | GRANT_AWARD | Viking Therapeutics, Inc. | 21 667 | 0.00 USD | |
| 06 janv. 2025 | SALE | Viking Therapeutics, Inc. | 4 700 | 43.32 USD | |
| 06 janv. 2025 | SALE | Viking Therapeutics, Inc. | 45 609 | 42.69 USD | |
| 03 janv. 2025 | GRANT_AWARD | Viking Therapeutics, Inc. | 37 200 | 0.00 USD | deriv |
| 28 oct. 2024 | EXERCISE | Viking Therapeutics, Inc. | 51 000 | 8.52 USD | |
| 28 oct. 2024 | SALE | Viking Therapeutics, Inc. | 49 672 | 74.56 USD | |
| 28 oct. 2024 | SALE | Viking Therapeutics, Inc. | 18 620 | 75.79 USD | |
| 28 oct. 2024 | SALE | Viking Therapeutics, Inc. | 9 265 | 76.94 USD | |
| 28 oct. 2024 | SALE | Viking Therapeutics, Inc. | 23 082 | 77.68 USD | |
| 28 oct. 2024 | SALE | Viking Therapeutics, Inc. | 15 825 | 78.69 USD | |
| 28 oct. 2024 | EXERCISE | Viking Therapeutics, Inc. | 26 000 | 5.80 USD | |
| 28 oct. 2024 | SALE | Viking Therapeutics, Inc. | 7 967 | 80.65 USD | |
| 28 oct. 2024 | SALE | Viking Therapeutics, Inc. | 1 206 | 81.44 USD |